Gene therapy for aromatic L-amino acid decarboxylase deficiency: requirements for safe application and knowledge-generating follow-up

The autosomal recessive defect of aromatic L-amino acid decarboxylase (AADC) leads to a severe neurological disorder with manifestation in infancy due to a pronounced, combined deficiency of dopamine, serotonin and catecholamines. The success of conventional drug treatment is very limited, especiall...

Full description

Saved in:
Bibliographic Details
Main Authors: Roubertie, Agathe (Author) , Opladen, Thomas (Author) , Brennenstuhl, Heiko (Author) , Kuseyri Hübschmann, Oya (Author) , Flint, Lisa (Author) , Willemsen, Michel A. (Author) , Leuzzi, Vincenzo (Author) , Cazorla, Angels Garcia (Author) , Kurian, Manju A. (Author) , François-Heude, Marie Céline (Author) , Hwu, Paul (Author) , Zeev, Bruria Ben (Author) , Kiening, Karl (Author) , Roujeau, Thomas (Author) , Pons, Roser (Author) , Pearson, Toni S. (Author)
Format: Article (Journal)
Language:English
Published: 04 July 2023
In: Journal of inherited metabolic disease
Year: 2023, Pages: 1-13
ISSN:1573-2665
DOI:10.1002/jimd.12649
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/jimd.12649
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.12649
Get full text
Author Notes:Agathe Roubertie, Thomas Opladen, Heiko Brennenstuhl, Oya Kuseyri Hübschmann, Lisa Flint, Michel A. Willemsen, Vincenzo Leuzzi, Angels Garcia Cazorla, Manju A. Kurian, Marie Céline François-Heude, Paul Hwu, Bruria Ben Zeev, Karl Kiening, Thomas Roujeau, Roser Pons, Toni S. Pearson

MARC

LEADER 00000caa a22000002c 4500
001 1855006219
003 DE-627
005 20240306103805.0
007 cr uuu---uuuuu
008 230809s2023 xx |||||o 00| ||eng c
024 7 |a 10.1002/jimd.12649  |2 doi 
035 |a (DE-627)1855006219 
035 |a (DE-599)KXP1855006219 
035 |a (OCoLC)1425058969 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Roubertie, Agathe  |e VerfasserIn  |0 (DE-588)1298874785  |0 (DE-627)1855006995  |4 aut 
245 1 0 |a Gene therapy for aromatic L-amino acid decarboxylase deficiency  |b requirements for safe application and knowledge-generating follow-up  |c Agathe Roubertie, Thomas Opladen, Heiko Brennenstuhl, Oya Kuseyri Hübschmann, Lisa Flint, Michel A. Willemsen, Vincenzo Leuzzi, Angels Garcia Cazorla, Manju A. Kurian, Marie Céline François-Heude, Paul Hwu, Bruria Ben Zeev, Karl Kiening, Thomas Roujeau, Roser Pons, Toni S. Pearson 
264 1 |c 04 July 2023 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.08.2023 
520 |a The autosomal recessive defect of aromatic L-amino acid decarboxylase (AADC) leads to a severe neurological disorder with manifestation in infancy due to a pronounced, combined deficiency of dopamine, serotonin and catecholamines. The success of conventional drug treatment is very limited, especially in patients with a severe phenotype. The development of an intracerebral AAV2-based gene delivery targeting the putamen or substantia nigra started more than 10 years ago. Recently, the putaminally-delivered construct, Eladocagene exuparvovec has been approved by the European Medicines Agency and by the British Medicines and Healthcare products Regulatory Agency. This now available gene therapy provides for the first time also for AADC deficiency (AADCD) a causal therapy, leading this disorder into a new therapeutic era. By using a standardized Delphi approach members of the International Working Group on Neurotransmitter related Disorders (iNTD) developed structural requirements and recommendations for the preparation, management and follow-up of AADC deficiency patients who undergo gene therapy. This statement underlines the necessity of a framework for a quality-assured application of AADCD gene therapy including Eladocagene exuparvovec. Treatment requires prehospital, inpatient and posthospital care by a multidisciplinary team in a specialized and qualified therapy center. Due to lack of data on long-term outcomes and the comparative efficacy of alternative stereotactic procedures and brain target sites, a structured follow-up plan and systematic documentation of outcomes in a suitable, industry-independent registry study are necessary. 
650 4 |a AADCD 
650 4 |a Aromatic L-amino acid decarboxylase 
650 4 |a Eladocagene exuparvovec 
650 4 |a gene therapy 
650 4 |a iNTD registry 
650 4 |a neurotransmitter 
700 1 |a Opladen, Thomas  |d 1974-  |e VerfasserIn  |0 (DE-588)124489656  |0 (DE-627)642820481  |0 (DE-576)335321291  |4 aut 
700 1 |a Brennenstuhl, Heiko  |d 1987-  |e VerfasserIn  |0 (DE-588)1105686965  |0 (DE-627)862755344  |0 (DE-576)473681382  |4 aut 
700 1 |a Kuseyri Hübschmann, Oya  |d 1985-  |e VerfasserIn  |0 (DE-588)1038105617  |0 (DE-627)756673372  |0 (DE-576)392127156  |4 aut 
700 1 |a Flint, Lisa  |e VerfasserIn  |4 aut 
700 1 |a Willemsen, Michel A.  |e VerfasserIn  |4 aut 
700 1 |a Leuzzi, Vincenzo  |e VerfasserIn  |4 aut 
700 1 |a Cazorla, Angels Garcia  |e VerfasserIn  |4 aut 
700 1 |a Kurian, Manju A.  |e VerfasserIn  |4 aut 
700 1 |a François-Heude, Marie Céline  |e VerfasserIn  |4 aut 
700 1 |a Hwu, Paul  |e VerfasserIn  |4 aut 
700 1 |a Zeev, Bruria Ben  |e VerfasserIn  |4 aut 
700 1 |a Kiening, Karl  |d 1959-  |e VerfasserIn  |0 (DE-588)128746262  |0 (DE-627)379124599  |0 (DE-576)297310917  |4 aut 
700 1 |a Roujeau, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Pons, Roser  |e VerfasserIn  |4 aut 
700 1 |a Pearson, Toni S.  |e VerfasserIn  |0 (DE-588)1225140625  |0 (DE-627)1744751935  |4 aut 
773 0 8 |i Enthalten in  |t Journal of inherited metabolic disease  |d Hoboken, NJ : Wiley, 1978  |g (2023), Seite 1-13  |h Online-Ressource  |w (DE-627)320457753  |w (DE-600)2006875-X  |w (DE-576)105704652  |x 1573-2665  |7 nnas  |a Gene therapy for aromatic L-amino acid decarboxylase deficiency requirements for safe application and knowledge-generating follow-up 
773 1 8 |g year:2023  |g pages:1-13  |g extent:13  |a Gene therapy for aromatic L-amino acid decarboxylase deficiency requirements for safe application and knowledge-generating follow-up 
856 4 0 |u https://doi.org/10.1002/jimd.12649  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/jimd.12649  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230809 
993 |a Article 
994 |a 2023 
998 |g 128746262  |a Kiening, Karl  |m 128746262:Kiening, Karl  |d 910000  |d 911200  |d 50000  |e 910000PK128746262  |e 911200PK128746262  |e 50000PK128746262  |k 0/910000/  |k 1/910000/911200/  |k 0/50000/  |p 13 
998 |g 1038105617  |a Kuseyri Hübschmann, Oya  |m 1038105617:Kuseyri Hübschmann, Oya  |d 910000  |d 910500  |e 910000PK1038105617  |e 910500PK1038105617  |k 0/910000/  |k 1/910000/910500/  |p 4 
998 |g 1105686965  |a Brennenstuhl, Heiko  |m 1105686965:Brennenstuhl, Heiko  |d 910000  |d 911500  |e 910000PB1105686965  |e 911500PB1105686965  |k 0/910000/  |k 1/910000/911500/  |p 3 
998 |g 124489656  |a Opladen, Thomas  |m 124489656:Opladen, Thomas  |d 50000  |d 910000  |d 910500  |e 50000PO124489656  |e 910000PO124489656  |e 910500PO124489656  |k 0/50000/  |k 0/910000/  |k 1/910000/910500/  |p 2 
999 |a KXP-PPN1855006219  |e 4364165867 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Agathe","role":"aut","family":"Roubertie","display":"Roubertie, Agathe"},{"display":"Opladen, Thomas","family":"Opladen","given":"Thomas","role":"aut"},{"given":"Heiko","role":"aut","family":"Brennenstuhl","display":"Brennenstuhl, Heiko"},{"family":"Kuseyri Hübschmann","given":"Oya","role":"aut","display":"Kuseyri Hübschmann, Oya"},{"family":"Flint","given":"Lisa","role":"aut","display":"Flint, Lisa"},{"display":"Willemsen, Michel A.","family":"Willemsen","given":"Michel A.","role":"aut"},{"family":"Leuzzi","role":"aut","given":"Vincenzo","display":"Leuzzi, Vincenzo"},{"display":"Cazorla, Angels Garcia","given":"Angels Garcia","role":"aut","family":"Cazorla"},{"given":"Manju A.","role":"aut","family":"Kurian","display":"Kurian, Manju A."},{"display":"François-Heude, Marie Céline","family":"François-Heude","role":"aut","given":"Marie Céline"},{"family":"Hwu","role":"aut","given":"Paul","display":"Hwu, Paul"},{"family":"Zeev","given":"Bruria Ben","role":"aut","display":"Zeev, Bruria Ben"},{"family":"Kiening","given":"Karl","role":"aut","display":"Kiening, Karl"},{"family":"Roujeau","given":"Thomas","role":"aut","display":"Roujeau, Thomas"},{"display":"Pons, Roser","role":"aut","given":"Roser","family":"Pons"},{"given":"Toni S.","role":"aut","family":"Pearson","display":"Pearson, Toni S."}],"title":[{"title_sort":"Gene therapy for aromatic L-amino acid decarboxylase deficiency","title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency","subtitle":"requirements for safe application and knowledge-generating follow-up"}],"language":["eng"],"physDesc":[{"extent":"13 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1002/jimd.12649"],"eki":["1855006219"]},"origin":[{"dateIssuedDisp":"04 July 2023","dateIssuedKey":"2023"}],"name":{"displayForm":["Agathe Roubertie, Thomas Opladen, Heiko Brennenstuhl, Oya Kuseyri Hübschmann, Lisa Flint, Michel A. Willemsen, Vincenzo Leuzzi, Angels Garcia Cazorla, Manju A. Kurian, Marie Céline François-Heude, Paul Hwu, Bruria Ben Zeev, Karl Kiening, Thomas Roujeau, Roser Pons, Toni S. Pearson"]},"recId":"1855006219","note":["Gesehen am 09.08.2023"],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"JIMD"}],"note":["Gesehen am 11.03.20","Ungezählte Beil.: Suppl"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1978 -"],"language":["eng"],"title":[{"title_sort":"Journal of inherited metabolic disease","title":"Journal of inherited metabolic disease","subtitle":"JIMD ; official journal of the Society for the Study of Inborn Errors of Metabolism"}],"recId":"320457753","disp":"Gene therapy for aromatic L-amino acid decarboxylase deficiency requirements for safe application and knowledge-generating follow-upJournal of inherited metabolic disease","id":{"doi":["10.1002/(ISSN)1573-2665"],"eki":["320457753"],"zdb":["2006875-X"],"issn":["1573-2665"]},"origin":[{"publisherPlace":"Hoboken, NJ ; Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedDisp":"1978-","dateIssuedKey":"1978","publisher":"Wiley ; Kluwer ; Springer Science + Business Media B.V"}],"part":{"year":"2023","text":"(2023), Seite 1-13","extent":"13","pages":"1-13"}}]} 
SRT |a ROUBERTIEAGENETHERAP0420